TG Therapeutics Inc (TGTX)

Quick ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash	US$ in thousands	92,933	102,304	298,887	553,439	112,637
Short-term investments	US$ in thousands	124,575	59,374	15,876	51,987	27,798
Receivables	US$ in thousands	51,093	0	1,389	—	—
Total current liabilities	US$ in thousands	53,720	53,201	65,384	87,554	84,449
Quick ratio		5.00	3.04	4.84	6.91	1.66

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($92,933K + $124,575K + $51,093K) ÷ $53,720K
= 5.00

The quick ratio of TG Therapeutics Inc has shown some fluctuations over the past five years. The quick ratio was relatively low in 2019 at 1.66, indicating lower short-term liquidity. However, the quick ratio improved significantly in 2020 to 6.91, showing a strong ability to cover its short-term obligations with its most liquid assets. Subsequently, in 2021 and 2023, the quick ratio remained high at 4.84 and 5.00, respectively, suggesting continued strong liquidity position. However, there was a slight decrease in 2022 to 3.04, although it still indicates a healthy liquidity position overall. Overall, TG Therapeutics Inc has maintained a strong quick ratio, which demonstrates its ability to meet short-term obligations using its liquid assets.